Search Results 2701-2710 of 16214 for chemoprevention
It's a time of year to raise awareness for breast cancer, especially since Michelle is not far removed from her initial diagnosis, treatment and recovery.
The purpose of this study is to evaluate immunogenicity of the vaccine, assessed at week 12, based on the increase in IgG anti-MUC1 antibody titer over the pre- ...
Because Medicaid requires little to no insurance premium or out of pocket, traditional copay and grant assistance programs are limited. However, it is important ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic. Give Today · Find a doctor · Explore careers.
The primary purpose of this study is to assess the benefits and risks of changing from Cyclosporine or Tacrolimus to Belatacept between 6-60 months after kidney ...
Title: NRG-GY012, A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, ...
Cholangiocarcinoma (CCA) has key similarities with HCC, therefore, we hypothesize that Sulf1 and Sulf2 may also play roles in promotion of CCA progression.
Part A (dose regimen finding) will allow definition of the maximum tolerated dose (MTD) through dose escalation and possible dose interval modification. In Part ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.